RecruitingNCT07485829

Zimmer Biomet-RibFix Titan

Zimmer Biomet Patient Outcomes and Experience After Chest Wall Repair With RibFix Titan™

Sponsor

Zimmer Biomet

Enrollment

54 participants

Start Date

Mar 31, 2026

Study Type

OBSERVATIONAL

Conditions

rib fracture Rib Fracture Multiple

Summary

Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying The RibFix Titan™ device should be used within this arm of the study. for people with rib fracture multiple and rib fracture. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.